William Audeh, Chief Medical Officer at Agendia

William Audeh

Chief Medical Officer at Agendia | Oceanside, California, United States

Profile last verified October 2026
Hospital & Health Care Verified Profile Oceanside, California, United States Stanford University
Verified

Work Email

***@agendia.com

Last verified May 2026

Phone Number

310*****

United States • Mobile

Free account · No credit card · 5 profiles/month

William Audeh Socials
William Audeh Work Experience

Medical Oncologist- Medical Staff at Cedars-Sinai Medical Center in August 1989 - Present

Chief Medical Advisor at BATech in September 2023 - Present

Chief Medical Officer at Agendia in May 2016 - Present

See more See less

Associate Clinical Professor of Medicine at University of California, Los Angeles in January 1995 - January 2018

Breast Cancer Program: Medical Oncology Faculty/ Samuel Oschin Cancer Institute at Cedars-Sinai Medical Center in October 2009 - May 2016

Executive Committee Member/ Samuel Oschin Cancer Institute at Cedars-Sinai Medical Center in October 2009 - May 2016

Medical Director, Cancer Center at Cedars-Sinai Medical Center in October 2009 - October 2012

William Audeh Education

Stanford University, Fellowship, November 1986 to November 1989

Stanford University, Chief Resident, November 1985 to November 1986

Stanford University, Internship/Residency, November 1982 to November 1985

See more See less

University of Iowa, November 1978 to November 1982

University of Minnesota-Twin Cities, Master's degree, November 1977 to November 1978

Carleton College, BA, November 1973 to November 1977

William Audeh Skills
Biotechnology Breast Cancer Cancer Clinical Research Clinical Trials EHR EMR Healthcare Healthcare Information Technology Healthcare Management Hospitals Lifesciences Medical Education Oncology Strategic Planning Medicine
About William Audeh’s Current Company
Agendia

Agendia is a precision oncology company headquartered in Irvine, California, committed to bringing patients with early stage breast cancer and their physicians the information they need to make the best decisions for the full treatment journey. The company currently offers two commercially-available genomic profiling tests, supported by the highest levels of clinical and real world evidence, that provide comprehensive genomic information that can be used to identify the most effective breast cancer treatment possible for each patient. MammaPrint®, the 70-gene breast cancer recurrence assay, is the only FDA-cleared risk of recurrence test backed by peer-reviewed, prospective outcome data and inclusion in both national and international treatment guidelines. BluePrint®, the 80-gene molecular subtyping assay, is the only commercially-available test that evaluates the underlying biology of a tumor to determine what is driving its growth. Together, MammaPrint® and BluePrint® provide a comprehensive genomic profile to help physicians make more informed decisions in the pre- and post-operative treatment settings. Agendia develops evidence-based novel genomic tests and forges partnerships with groundbreaking companies to develop next-generation digital treatment tools. The ongoing research builds an arsenal of data that improve patient outcomes and support the evolving clinical needs of patients with breast cancer and their physicians every step of the way, from initial diagnosis to cancer-free. Agendia’s assays can be ordered on core biopsies or surgical specimens to inform pre- and post-operative treatment decisions. For more information on Agendia’s assays and ongoing trials, please visit www.agendia.com. For view our social media policies, please visit https://agendia.com/legal-compliance/

Discover more about Agendia
William Audeh’s Colleagues
Nicole Stivers

Nicole Stivers

Irvine, California, United States

Breast Cancer Genomics 🧬 Agendia | Medical Publication Writer | CMPP

Medical Publications Writer at Agendia
(November 2023 – Present)

Suzye Bucher

Suzye Bucher

Scottsdale, Arizona, United States

Senior Molecular Oncology Specialist 🧬

Senior Molecular Oncology Specialist at Agendia
(Oct 2025 – Present)

Brandon H

Brandon H

United States

Director at Agendia, Inc.

Director, Capital Markets & Investments at Agendia
(Jan 2024 – Present)

Scott Mcveigh

Scott Mcveigh

United States

Senior Molecular Oncology Specialist - North Texas - Agendia

Senior Molecular Oncology Specialist at Agendia
(Sep 2020 – Present)

Delaina S

Delaina S

Atlanta, Georgia, United States

Field Leadership | Regional Sales Director at Agendia

Regional Sales Director at Agendia
(Nov 2025 – Present)

Sahra Uygun

Sahra Uygun

Los Angeles Metropolitan Area

Principal Scientist | Bioinformatics | Clinical Data Science | Oncology | Real-World Evidence

- Lead clinical and bioinformatics projects integrating transcriptomic and real-world evidence (RWE) data to inform precision oncology research
- Support data interpretation, and manuscript development in collaboration with KOLs and Medical Affairs
- Implement automation workf...

Search similar profiles
Frequently asked questions about William Audeh

What is William Audeh phone number?

William Audeh phone number is 3109179241 and 3108490561.

How to contact William Audeh?

If you want to call William Audeh try calling on 3109179241 and 3108490561. (updated on September 29, 2025)

What company does William Audeh work for?

William Audeh works for Agendia.

What is William Audeh's role at Agendia?

William Audeh is Chief Medical Officer

What industry does William Audeh work in?

William Audeh works in the Hospital & Health Care industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free